Purpose: High dose total body irradiation (TBI) in combination with chemoth
erapy, followed by rescue with bone marrow transplantation (BMT), is increa
singly used for the treatment of haematological malignancies. With the incr
easing success of this treatment and its current introduction for treating
refractory autoimmune diseases the risk of radiation carcinogenesis is of g
rowing concern. Studies on tumour induction in non-human primates are of re
levance in this context since the response of this species to radiation doe
s not differ much from that in man.
Materials and methods: Since the early sixties, studies have been performed
on acute effects in Rhesus monkeys and the protective action of bone marro
w transplantation after irradiation with X-rays (average total body dose 6.
8 Gy) and fission neutrons (average dose 3.4 Gy). Of those monkeys, which w
ere irradiated and reconstituted with autologous bone marrow, 20 animals in
the X-irradiated group and nine animals in the neutron group survived more
than 3 years. A group of 21 non-irradiated Rhesus monkeys of a comparable
age distribution served as controls. All animals were regularly screened fo
r the occurrence of neoplasms. Complete necropsies were performed after nat
ural death or euthanasia.
Results: At post-irradiation intervals of 4-21 years an appreciable number
of tumours was observed. In the neutron irradiated group eight out of nine
animals died with one or more malignant tumours. In the X-irradiated group
this fraction was 10 out of 20. The tumours in the control group, in seven
out of the 21 animals, appeared at much older age compared with those in th
e irradiated cohorts. The histogenesis of the rumours was diverse with a pr
eponderance of renal carcinoma, sarcomas among which osteosarcomas, and mal
ignant glomus rumours in the irradiated groups.
Conclusions: When corrected for competing risks, the carcinogenic risk of T
BI in the Rhesus monkeys is similar to that derived from the studies of the
Japanese atomic bomb survivors. The increase of the risk by a factor of 8,
observed in the monkeys, indicates that patients are likely to develop mal
ignancies more frequently and much earlier in life after TBI than non-expos
ed individuals. This finding underlines the necessity of regular screening
of long-term surviving patients subjected to TBI and BMT. (C) 2000 Elsevier
Science Ireland Ltd. All rights reserved.